A stockout of the version of testosterone (made by Pfizer) used by state facilities and nonprofits is entering its second year. It’s left transgender men in South Africa, who use the hormone as part of gender-affirming treatment, with few options. Find out what lengths they’re forced to go to get the medicine.
